ABZORVE Trademark

Trademark Overview


On Tuesday, May 27, 2025, a trademark application was filed for ABZORVE with the United States Patent and Trademark Office. The USPTO has given the ABZORVE trademark a serial number of 99203958. The federal status of this trademark filing is REGISTERED as of Tuesday, January 6, 2026. This trademark is owned by Glaxo Group Limited. The ABZORVE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
abzorve

General Information


Serial Number99203958
Word MarkABZORVE
Filing DateTuesday, May 27, 2025
Status700 - REGISTERED
Status DateTuesday, January 6, 2026
Registration Number8094132
Registration DateTuesday, January 6, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2025

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Tuesday, May 27, 2025NEW APPLICATION ENTERED
Tuesday, May 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 27, 2025APPLICATION FILING RECEIPT MAILED
Monday, September 15, 2025ASSIGNED TO EXAMINER
Wednesday, October 15, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 6, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, January 6, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED